Skip to content

Proteomic Assessment of Preterm Birth

Proteomic Assessment of Preterm Birth

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01371019
Acronym
PAPR
Enrollment
5500
Registered
2011-06-10
Start date
2011-04-30
Completion date
2015-04-30
Last updated
2015-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth

Keywords

Preterm Birth, Proteomics

Brief summary

The purpose of this study is to to collect and store blood samples that will be utilized to develop a multimarker test to predict preterm delivery.

Interventions

None listed

Sponsors

Sera Prognostics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Subject is 18 years or older. * Subject has a singleton pregnancy. * Subject is able to provide consent.

Exclusion criteria

* Subject is pregnant with more than one fetus. * There is a known or suspected fetal anomaly.

Design outcomes

Primary

MeasureTime frame
Spontaneous Preterm BirthAugust 2015

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026